Biohaven shareholders approve 2026 meeting proposals
Biohaven Ltd. reported the results of its 2026 annual meeting of shareholders.
Rhea-AI Filing Summary
Biohaven Ltd. reported the results of its 2026 annual meeting of shareholders. Shareholders elected Michael T. Heffernan, Irina Antonijevic, M.D., Ph.D., and Robert J. Hugin as directors for terms expiring at the 2029 annual meeting, each receiving over 76 million votes in favor and more than 14 million votes against, with additional abstentions and 32,137,064 broker non-votes.
Shareholders also approved the ratification of Ernst & Young LLP as independent auditors for the fiscal year ending December 31, 2026, with 123,723,636 votes for, 214,123 against, and 1,410,634 abstentions. In addition, they approved the non-binding advisory vote on compensation for the company’s named executive officers, with 87,521,620 votes for, 4,202,883 against, 1,486,826 abstentions, and 32,137,064 broker non-votes.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Votes for Heffernan: 76,133,746 votes
Votes for Antonijevic: 76,612,017 votes
Votes for Hugin: 76,597,707 votes
+4 more
7 metrics
Votes for Heffernan
76,133,746 votes
Election of director Michael T. Heffernan
Votes for Antonijevic
76,612,017 votes
Election of director Irina Antonijevic, M.D., Ph.D.
Votes for Hugin
76,597,707 votes
Election of director Robert J. Hugin
Auditor ratification for votes
123,723,636 votes
Ratification of Ernst & Young LLP for 2026
Auditor ratification against votes
214,123 votes
Opposed to Ernst & Young LLP ratification
Say-on-pay for votes
87,521,620 votes
Advisory vote on executive compensation
Broker non-votes on Proposals 1 & 3
32,137,064 votes
Director elections and say-on-pay
Key Terms
Annual Meeting, Broker Non-Votes, independent auditors, advisory vote, +2 more
6 terms
Annual Meeting financial
"held its 2026 annual meeting of shareholders (the “Annual Meeting”)."
A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.
Broker Non-Votes financial
"Broker Non-Votes: 32,137,064"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
independent auditors financial
"Ratification of the appointment of Ernst & Young LLP as independent auditors"
Independent auditors are outside, licensed accountants who examine a company’s books, records and internal controls and issue an objective opinion on whether the financial statements accurately reflect the business’s financial position. Investors treat their report like a neutral inspector’s stamp — it increases trust, makes financial results easier to compare, and alerts readers if there are errors, omissions or other problems that could affect investment decisions.
advisory vote financial
"Advisory vote on the compensation paid to the Company’s named executive officers."
An advisory vote is a shareholder poll that expresses investors’ approval or concern about a company’s policy, executive pay, board decisions or other governance matters but does not legally force the company to act. Think of it like a customer survey: it signals investor sentiment and can pressure management to change course, so investors watch the result as a guide to future governance, risk and potential shifts in strategy.
named executive officers financial
"compensation paid to the Company’s named executive officers."
Named executive officers are the senior company leaders whose names, roles and compensation are singled out in required regulatory filings; this typically includes the chief executive, chief financial officer and the next highest‑paid senior officers. Investors treat this list like a team roster — it shows who makes key decisions, how they are paid and whether incentives align with shareholder interests, so changes or pay patterns can signal governance quality, risk or strategic shifts.
Emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Which directors were elected at Biohaven Ltd. (BHVN)’s 2026 annual meeting?
Shareholders elected Michael T. Heffernan, Irina Antonijevic, M.D., Ph.D., and Robert J. Hugin as directors. Their terms will expire at the 2029 annual meeting of shareholders, and each nominee received over 76 million votes in favor, with additional votes against and abstentions.
What were the results of Biohaven Ltd. (BHVN)’s say-on-pay advisory vote in 2026?
Shareholders approved the non-binding advisory vote on compensation for Biohaven’s named executive officers. The proposal received 87,521,620 votes for, 4,202,883 against, and 1,486,826 abstentions, with 32,137,064 broker non-votes recorded on this executive compensation item.
Were there broker non-votes at Biohaven Ltd. (BHVN)’s 2026 annual meeting?
Yes. For the director elections and the advisory vote on executive compensation, there were 32,137,064 broker non-votes. For the proposal to ratify Ernst & Young LLP as independent auditors for 2026, there were zero broker non-votes reported in the voting results.
AI-generated analysis. How Rhea-AI works. Not financial advice.
